Losartan - Open Access .click

Results 1 to 10 of about 58,845 (265)

Differential involvement of hippocampal angiotensin 1 receptors in learning and memory processes in bulbectomized rats [PDF]

, 2016
There is conflicting evidence regarding the effect of AT1 receptor antagonists on learning and memory processes. The effects of angiotensin II and losartan administration into CA1 hippocampal area on the avoidance performance in olfactory bulbectomized ...
Belcheva, Iren +3 more
core +1 more source

Experimental rat models of chronic allograft nephropathy: a review [PDF]

, 2014
Chronic allograft nephropathy (CAN) is the leading cause of late allograft loss after renal transplantation (RT), which continues to remain an unresolved problem. A rat model of CAN was first described in 1969 by White et al. Although the rat model of RT
Haylor, John, Shrestha, Badri
core +2 more sources

Tetrahydrocurcumin Add‐On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury [PDF]

, 2023
Mahyar Khazaeli +7 more
openalex +1 more source

Losartan therapy and hyperuricemia correction in patients with metabolic syndrome and arterial hypertension

Кардиоваскулярная терапия и профилактика, 2011
Aim. To assess the potential of the angiotensin II receptor antagonist losartan for the correction of hyperuricemia (HU) in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods.
S. V. Nedogoda +3 more
doaj +1 more source

Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?

International Journal of Nephrology and Renovascular Disease, 2010
Elizabeth Ripley, Ari HirschDivision of Nephrology, Virginia Commonwealth University, Richmond, Virginia, USAAbstract: Losartan, the first AT1 receptor blocker (ARB), was FDA approved 15 years ago.During those years, researchers and clinicians have ...
Elizabeth Ripley, Ari Hirsch
doaj

Quality of Life and Antihypertensive Effect With Nebivolol and Losartan [PDF]